Trial · NCT01475721
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
Number of Participants Experiencing an Event in the Composite Safety Endpoint of Serious Asthma Outcomes ( Asthma-related Hospitalization, Asthma-related Endotracheal Intubation, or Asthma-related Death) | Fluticasone Propionate/Salmeterol Combination (FSC) | 34 | Participants | ||
Number of Participants Experiencing an Event in the Composite Safety Endpoint of Serious Asthma Outcomes ( Asthma-related Hospitalization, Asthma-related Endotracheal Intubation, or Asthma-related Death) | Fluticasone Propionate (FP) | 33 | Participants | ||
| Number of Participants Experiencing at Least One Asthma Exacerbation | Fluticasone Propionate/Salmeterol Combination (FSC) | 480 | Participants | ||
| Number of Participants Experiencing at Least One Asthma Exacerbation | Fluticasone Propionate (FP) | 597 | Participants | ||
| Number of Participants Experiencing at Least One Asthma Related Hospitalization , Endotracheal Intubation and Death | Fluticasone Propionate/Salmeterol Combination (FSC) | Hospitalization | 34 | Participants | |
| Number of Participants Experiencing at Least One Asthma Related Hospitalization , Endotracheal Intubation and Death | Fluticasone Propionate (FP) | Hospitalization | 33 | Participants | |
| Number of Participants Experiencing at Least One Asthma Related Hospitalization , Endotracheal Intubation and Death | Fluticasone Propionate/Salmeterol Combination (FSC) | Endotracheal intubation | 0 | Participants | |
| Number of Participants Experiencing at Least One Asthma Related Hospitalization , Endotracheal Intubation and Death | Fluticasone Propionate (FP) | Endotracheal intubation | 2 | Participants | |
| Number of Participants Experiencing at Least One Asthma Related Hospitalization , Endotracheal Intubation and Death | Fluticasone Propionate/Salmeterol Combination (FSC) | Death | 0 | Participants | |
| Number of Participants Experiencing at Least One Asthma Related Hospitalization , Endotracheal Intubation and Death | Fluticasone Propionate (FP) | Death | 0 | Participants | |
| Number of Participant Withdrawals From Study Treatment Due to Asthma Exacerbation | Fluticasone Propionate/Salmeterol Combination (FSC) | 66 | Participants | ||
| Number of Participant Withdrawals From Study Treatment Due to Asthma Exacerbation | Fluticasone Propionate (FP) | 84 | Participants | ||
| Mean Rescue Medication (Albuterol/Salbutamol) Use as Puffs Per 24 Hours | Fluticasone Propionate/Salmeterol Combination (FSC) | 0.90 | Standard Error 0.018 | Number of Puffs | |
| Mean Rescue Medication (Albuterol/Salbutamol) Use as Puffs Per 24 Hours | Fluticasone Propionate (FP) | 1.09 | Standard Error 0.020 | Number of Puffs |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01475721/results